Longevity
Vesilute
Other
3
Amino acids
Molecular weight
Peptide
Type
Vesilute is a Khavinson bioregulator dipeptide consisting of glutamic acid and aspartic acid (ED), developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is specifically designed to support bladder and urinary tract function, with research indicating potential benefits for prostate health in men. Vesilute may help regulate smooth muscle function, enhance tissue blood flow, and support cellular regeneration in urogenital tissues. It is distinct from Vesugen (KED tripeptide), which targets vascular endothelium.
Top researched benefits
Overview of Vesilute
Vesilute acts on the smooth muscle cells and vascular endothelium of the urogenital system. It is proposed to: (1) regulate smooth muscle contraction and relaxation in the bladder wall, (2) enhance microcirculation and blood flow in pelvic tissues including prostate, (3) support cellular regeneration and tissue repair in the urinary tract, (4) reduce hyperemia and inflammation-related dysfunction, and (5) modulate gene expression related to urogenital tissue homeostasis through bioregulation pathways characteristic of Khavinson peptides.
Urinary Tract Health
- Research explores relief of symptoms associated with bladder dysfunction through smooth muscle regulation.
- May support overall urinary tract function and tissue health.
- Potential benefits for pelvic tissue health and function.
Prostate Health Men
- Research indicates potential to enhance blood flow and reduce dysfunction in prostate tissue.
- May help alleviate symptoms associated with benign prostatic hyperplasia.
Antiaging Protocol
- Part of comprehensive bioregulator protocols addressing age-related urogenital changes.
- Supports cellular regeneration in urinary and reproductive tissues.
Storage
Lyophilized powder: room temperature or 2-8°C; Reconstituted: 2-8°C refrigerated, use within 4 weeks
Frequency
Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Typical Dose
10-20 mg per day
Cycle Duration
10-20 day cycle
Chemical Makeup
Key benefits
Supports bladder and urinary tract function
May improve prostate health in men
Regulates smooth muscle function
Enhances pelvic tissue blood flow
Supports cellular regeneration
Part of comprehensive Khavinson bioregulator protocols
Well-tolerated in research
Oral bioavailability as small dipeptide
Community interest
This peptide is still gaining traction in the community.
ED Dipeptide | Bladder & Urinary Tract Bioregulator
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesVesilute Molecular Information
View the scientifc details of Vesilute.
3
Amino Acids
Vesilute
Lys
Lys
Position 1
Glu
Glu
Position 2
Asp
Asp
Position 3
Molecular Weight
390.39DaChain Length
3Amino AcidsType
PeptideVesilute Protocols
Injectable form for subcutaneous or intramuscular administration. Standard Khavinson protocol of 10-20 day cycles, repeated 2-3 times per year for maintenance.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10 | 10 week range | SubQ or IM |
| Maintenance | 20 | 2 week range | SubQ or IM |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- Clean work area thoroughly
- Reconstitute with bacteriostatic water
- Inject water slowly down vial wall
- Gently swirl until dissolved
- Store refrigerated at 2-8°C
- Use within 4 weeks of reconstitution
Vesilute Cycle
The Vesilute Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 0-0
- Tissue-specific effects begin; gene expression modulation
- Day 10-20
- Cellular function optimization in target tissues
- Week 0-0
- Effects persist due to bioregulation mechanisms
- Week 0-0
- Cumulative benefits with regular cycling; tissue health maintenance
Dosing tools
Vesilute Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Vesilute
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Vesilute vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Vesilute
- Dosing
- 10-20 mg per day
- Dosing Frequency
- Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
- Cycle Duration
- 10-20 day cycle
- Storage
- Lyophilized powder: room temperature or 2-8°C; Reconstituted: 2-8°C refrigerated, use within 4 weeks
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Vesilute interactions with other common peptides and substances.
Longevity
epi
Immunity
Epitalon
COMPATIBLE
Often combined in comprehensive anti-aging bioregulator protocols.
Sexual
pro
Prostamax
SYNERGISTIC
Both target prostate/urogenital health; can be combined for comprehensive support.
Longevity
thy
Immunity
Thymalin
COMPATIBLE
Different target systems; no known negative interactions.
Healing
vesu
Longevity
Vesugen
COMPATIBLE
Different targets - Vesugen for vascular, Vesilute for bladder/prostate. Can be combined.
Side effects
Contraindications
Known hypersensitivity to peptide components
Active urinary tract infection (treat first)
Pregnancy or breastfeeding
Prostate cancer (consult physician)
Stop signs
Signs of allergic reaction
Unusual urinary symptoms
Unexpected changes in urination patterns
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
VesiluteResearch References
Vesilute is a moderate research compound
Vesilute
Vesilute is a moderate research compound
Khavinson Bioregulator Peptides: Organ-Specific Effects
Vesilute (ED dipeptide) targets bladder and urinary tract tissues with bioregulatory effects.
n.d.
Short Peptides and Urogenital Function
ED dipeptide influences smooth muscle and vascular function in urogenital tissues.
n.d.
Bioregulators in Anti-Aging Medicine
Organ-specific peptide bioregulators including Vesilute support tissue-specific regeneration.
n.d.